We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

12 hedge funds and large institutions have $1.55M invested in Grace Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more capital invested

Capital invested by funds: $204K → $1.55M (+$1.35M)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

9% more funds holding

Funds holding: 11 → 12 (+1)

7.35% more ownership

Funds ownership: 0.15% → 7.49% (+7.3%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.17M
2
CBA
Coastal Bridge Advisors
Connecticut
+$23.7K
3
UBS Group
UBS Group
Switzerland
+$11.2K
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.96K
5
IPW
Impact Partnership Wealth
Georgia
+$24

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$35K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$9.63K
3
TSS
Two Sigma Securities
New York
-$7.92K
4
Jane Street
Jane Street
New York
-$7.46K
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$400
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$1.38M +$1.17M +494,698 New
TPCW
2
TD Private Client Wealth
New York
$110K -$2 -1 -0%
CBA
3
Coastal Bridge Advisors
Connecticut
$27.8K +$23.7K +10,000 New
UBS Group
4
UBS Group
Switzerland
$13.1K +$11.2K +4,712 New
JP Morgan Chase
5
JP Morgan Chase
New York
$9.2K +$7.96K +3,358 New
National Bank of Canada
6
National Bank of Canada
Quebec, Canada
$8.13K -$400 -169 -6%
Morgan Stanley
7
Morgan Stanley
New York
$5.24K -$2 -1 -0.1%
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$2K -$2 -1 -0.2%
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Quebec, Canada
$78 -$5 -2 -7%
IPW
10
Impact Partnership Wealth
Georgia
$28 +$24 +10 New
TWC
11
TD Waterhouse Canada
Ontario, Canada
$4 – – –
Renaissance Technologies
12
Renaissance Technologies
New York
– -$35K -11,267 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$9.63K -3,058 Closed
TSS
14
Two Sigma Securities
New York
– -$7.92K -2,515 Closed
Jane Street
15
Jane Street
New York
– -$7.46K -2,369 Closed
IGWM
16
ICA Group Wealth Management
Colorado
– -$29 -10 Closed
NS
17
NBC Securities
Alabama
– +$5 +2 New

GRCE Hedge Fund Activity: Q3 2023 in Review

12 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2023, worth a combined $1.55M — up 660% from $204K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GRCE positions and 5 closed out — a net gain of 1 holder — while 0 added to existing stakes and 5 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $1.17M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $35K sold.

  • 12 institutional investors held Grace Therapeutics (GRCE) as of Q3 2023, up from 11 in Q2 2023.
  • Funds reported $1.55M of Grace Therapeutics stock for Q3 2023, up 660% quarter-over-quarter.
  • 6 funds opened new Grace Therapeutics positions in Q3 2023 and 5 closed out, a net change of +1 holder.
  • The largest Grace Therapeutics buyer in Q3 2023 was Bank of America, an estimated $1.17M added.
  • The largest Grace Therapeutics seller in Q3 2023 was Renaissance Technologies, an estimated $35K sold.

Based on aggregated 13F filings for Q3 2023.